Anastasiou D: Difference between revisions
From Bioblast
(Created page with "{{Person |lastname=Anastasiou |firstname=Dimitrios |title= |[email protected] |address=Developmental Biology / Physiology and Metabolism / Stem Cell ...") |
No edit summary |
||
Line 2: | Line 2: | ||
|lastname=Anastasiou | |lastname=Anastasiou | ||
|firstname=Dimitrios | |firstname=Dimitrios | ||
|address=Developmental Biology / Physiology and Metabolism / Stem Cell Biology and Developmental Genetics / Systems Biology | |address=Developmental Biology / Physiology and Metabolism / Stem Cell Biology and Developmental Genetics / Systems Biology | ||
Line 11: | Line 9: | ||
London NW7 1AA, United Kingdom | London NW7 1AA, United Kingdom | ||
}} | }} | ||
{{Labelingperson}} |
Revision as of 17:07, 8 March 2016
Name | Anastasiou Dimitrios, |
---|---|
Institution | |
Address | Developmental Biology / Physiology and Metabolism / Stem Cell Biology and Developmental Genetics / Systems Biology
MRC National Institute for Medical Research The Ridgeway Mill Hill London NW7 1AA, United Kingdom, |
City | |
State/Province | |
Country | |
[email protected] | |
Weblink | |
O2k-Network Lab | UK London Anastasiou D |
Labels:
Publications
Published | Reference | |
---|---|---|
Fets 2022 Commun Biol | 2022 | Fets L, Bevan N, Nunes PM, Campos S, Dos Santos MS, Sherriff E, MacRae JI, House D, Anastasiou D (2022) MOG analogues to explore the MCT2 pharmacophore, α-ketoglutarate biology and cellular effects of N-oxalylglycine. https://doi.org/10.1038/s42003-022-03805-y |
Fets 2018 Nat Chem Biol | 2018 | Fets L, Driscoll PC, Grimm F, Jain A, Nunes PM, Gounis M, Doglioni G, Papageorgiou G, Ragan TJ, Campos S, Silva Dos Santos M, MacRae JI, O'Reilly N, Wright AJ, Benes CH, Courtney KD, House D, Anastasiou D (2018) MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG. Nat Chem Biol 14:1032-42. |